Trial Profile
The effect of sodium-glucose co-transporter 2 inhibition prior to atrial fibrillation ablation on electrophysiological and clinical markers of atrial fibrillation: A pilot randomised controlled trial.
Status:
Not yet recruiting
Phase of Trial:
Phase I/II
Latest Information Update: 10 Jun 2021
Price :
$35
*
At a glance
- Drugs Dapagliflozin (Primary)
- Indications Atrial fibrillation
- Focus Therapeutic Use
- 10 Jun 2021 New trial record